Skip to main content
. 2022 Nov 7;13:1041747. doi: 10.3389/fpsyt.2022.1041747

TABLE 1.

Descriptive statistics, ANOVA, and chi-squared test results.

Day-level variable
Overall (n = 2129)
MDD (n = 1023)
MDS (n = 661)
CON (n = 445)
P-value
Mean SE Mean SE Mean SE Mean SE

Sleep efficiency (%) 94.30 0.19 94.18 0.28 94.41 0.35 94.44 0.42 0.820

Person-level variable

Overall (N = 100)
MDD (N = 48)
MDS (N = 31)
CON (N = 21)
P-value
Sex
Male 40 (40.00%) 22 (45.83%) 10 (32.26%) 8 (38.10%) 0.476
Female 60 (60.00%) 26 (54.17%) 21 (67.74%) 13 (61.90%)

Mean SD Mean SD Mean SD Mean SD

Age 24.33 3.18 24.10 2.83 24.58 3.33 24.48 3.79 0.791
BED (min) 379.98 52.32 380.85 51.45 378.90 42.99 379.60 67.48 0.987
PHQ 8.77 5.12 11.06 4.61 8.81 4.48 3.48 2.77 <0.001
GAD 6.04 5.04 7.90 4.90 6.26 4.89 1.48 1.72 <0.001
QOL 48.39 9.61 44.06 7.82 49.13 9.62 57.19 6.94 <0.001
NEO1 39.05 5.96 38.85 6.30 39.45 5.97 38.90 5.35 0.904
NEO2 37.14 7.17 35.48 6.64 37.81 8.28 39.95 5.68 0.046
NEO3 34.07 6.96 33.15 7.34 33.00 6.62 37.76 5.42 0.022
NEO4 41.94 8.33 45.25 7.48 41.42 6.82 35.14 8.19 <0.001
NEO5 41.62 6.64 41.81 7.05 41.52 6.16 41.33 6.67 0.958
BIS 66.99 11.68 67.48 10.96 67.81 11.90 64.67 13.14 0.591
PSQI 7.83 2.85 8.44 2.71 7.23 3.06 7.33 2.65 0.121

The P-value reported in the sleep efficiency variable is a random ANOVA result that take into account the nested structure of the data, and the P-value described in the Sex variable is a result of the chi-squared test; MDD, major depressive disorder; MDS, mild depressive symptoms; CON, control; BED, time in bed; PHQ, Patient Health Questionnaire-9; GAD, General Anxiety Disease-7; QOL, WHO quality of life; NEO1, NEO agreeableness; NEO2, NEO conscientiousness; NEO3, NEO extraversion; NEO4, NEO neuroticism; NEO5, NEO openness to experience; BIS, Barratt Impulsiveness Scale-11; PSQI, Pittsburgh Sleep Quality Index.